289 related articles for article (PubMed ID: 36324813)
1. cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma.
Tripathi S; Najem H; Mahajan AS; Zhang P; Low JT; Stegh AH; Curran MA; Ashley DM; James CD; Heimberger AB
F1000Res; 2022; 11():1010. PubMed ID: 36324813
[TBL] [Abstract][Full Text] [Related]
2. Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma.
Low JT; Brown MC; Reitman ZJ; Bernstock JD; Markert JM; Friedman GK; Waitkus MS; Bowie ML; Ashley DM
J Clin Invest; 2024 Jan; 134(2):. PubMed ID: 38226619
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
4. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
Mekers VE; Kho VM; Ansems M; Adema GJ
Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
[TBL] [Abstract][Full Text] [Related]
6. Radiation-Induced Remodeling of the Tumor Microenvironment Through Tumor Cell-Intrinsic Expression of cGAS-STING in Esophageal Squamous Cell Carcinoma.
Nakajima S; Mimura K; Kaneta A; Saito K; Katagata M; Okayama H; Saito M; Saze Z; Watanabe Y; Hanayama H; Tada T; Sakamoto W; Momma T; Ohira H; Kono K
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):957-971. PubMed ID: 36368436
[TBL] [Abstract][Full Text] [Related]
7. cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.
Pépin G; Gantier MP
Adv Exp Med Biol; 2017; 1024():175-194. PubMed ID: 28921470
[TBL] [Abstract][Full Text] [Related]
8. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
Guo J; Huang L
Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
[TBL] [Abstract][Full Text] [Related]
9. Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies.
Huang M; Cha Z; Liu R; Lin M; Gafoor NA; Kong T; Ge F; Chen W
Front Immunol; 2024; 15():1399926. PubMed ID: 38817608
[TBL] [Abstract][Full Text] [Related]
10. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches.
Khoo LT; Chen LY
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30446584
[TBL] [Abstract][Full Text] [Related]
11. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.
Kabashima A; Matsuo Y; Ito S; Akiyama Y; Ishii T; Shimada S; Masamune A; Tanabe M; Tanaka S
Sci Rep; 2022 Jun; 12(1):10466. PubMed ID: 35773436
[TBL] [Abstract][Full Text] [Related]
12. The STING pathway: Therapeutic vulnerabilities in ovarian cancer.
Shakfa N; Li D; Nersesian S; Wilson-Sanchez J; Koti M
Br J Cancer; 2022 Sep; 127(4):603-611. PubMed ID: 35383278
[TBL] [Abstract][Full Text] [Related]
13. Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer.
Kaneta A; Nakajima S; Okayama H; Matsumoto T; Saito K; Kikuchi T; Endo E; Ito M; Mimura K; Kanke Y; Saito M; Saze Z; Fujita S; Sakamoto W; Onozawa H; Momma T; Ohki S; Kono K
Cancer Immunol Immunother; 2022 Nov; 71(11):2765-2776. PubMed ID: 35429245
[TBL] [Abstract][Full Text] [Related]
14. Baculovirus Transduction in Mammalian Cells Is Affected by the Production of Type I and III Interferons, Which Is Mediated Mainly by the cGAS-STING Pathway.
Amalfi S; Molina GN; Bevacqua RJ; López MG; Taboga O; Alfonso V
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796076
[TBL] [Abstract][Full Text] [Related]
15. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy.
Luo K; Li N; Ye W; Gao H; Luo X; Cheng B
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509
[TBL] [Abstract][Full Text] [Related]
16. PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma.
Mondal I; Das O; Sun R; Gao J; Yu B; Diaz A; Behnan J; Dubey A; Meng Z; Eskandar E; Xu B; Lu RO; Ho WS
Cancer Res; 2023 Aug; 83(15):2527-2542. PubMed ID: 37219874
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of stimulator of interferon genes (STING) expression and CD8
Fukai S; Nakajima S; Saito M; Saito K; Kase K; Nakano H; Sato T; Sakuma M; Kaneta A; Okayama H; Mimura K; Sakamoto W; Saze Z; Momma T; Kono K
Gastric Cancer; 2023 Nov; 26(6):878-890. PubMed ID: 37542528
[TBL] [Abstract][Full Text] [Related]
18. Potential role of cGAS/STING pathway in regulating cancer progression.
Dhanisha SS; Guruvayoorappan C
Crit Rev Oncol Hematol; 2022 Oct; 178():103780. PubMed ID: 35953012
[TBL] [Abstract][Full Text] [Related]
19. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
[TBL] [Abstract][Full Text] [Related]
20. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer.
Kwon J; Bakhoum SF
Cancer Discov; 2020 Jan; 10(1):26-39. PubMed ID: 31852718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
